FDA

News and Updates by the Food and Drugs Administration (FDA)

BeiGene Secures Worldwide Licensing Deal with CSPC Zhongqi Pharma for MAT2A Inhibitor in Solid Tumor Treatment

BeiGene, Ltd., soon to be rebranded as BeOne Medicines Ltd., has disclosed a global licensing deal with CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. (CSPC) for SYH2039. This innovative methionine adenosyltransferase 2A (MAT2A) inhibitor is in exploration for potential uses […]

BeiGene Secures Worldwide Licensing Deal with CSPC Zhongqi Pharma for MAT2A Inhibitor in Solid Tumor Treatment Read More »

Ibrance Combined with Standard Treatments Enhances Median PFS by Over 15 Months in Phase 3 PATINA Trial for HR+, HER2+ Metastatic Breast Cancer

Pfizer Inc., in collaboration with Alliance Foundation Trials, LLC (AFT), has shared outcomes from the phase 3 PATINA trial. The investigation highlighted that incorporating Ibrance (palbociclib) into the existing standard first-line maintenance treatment (post induction chemotherapy) significantly boosted progression-free survival

Ibrance Combined with Standard Treatments Enhances Median PFS by Over 15 Months in Phase 3 PATINA Trial for HR+, HER2+ Metastatic Breast Cancer Read More »

EMA Grants Approval for Roche’s Vabysmo Prefilled Syringe for Trio of Vision-Threatening Retinal Disorders

Roche has announced that the European Medicines Agency (EMA) has given the green light to Vabysmo (faricimab) 6.0 mg prefilled syringe for the treatment of neovascular or ‘wet’ age-related macular degeneration (nAMD), diabetic macular edema (DME), and macular edema following

EMA Grants Approval for Roche’s Vabysmo Prefilled Syringe for Trio of Vision-Threatening Retinal Disorders Read More »

AI, Robotics, and Sustainability to Drive a Tailored Healthcare Environment by 2025, Predicts Atul Kurani

The healthcare sector stands on the verge of a revolutionary transformation, propelled by innovative technologies and changing patient expectations, leading to a shift towards a more customized and sustainable care environment. Atul Kurani, the Vice President of Global Health Medical

AI, Robotics, and Sustainability to Drive a Tailored Healthcare Environment by 2025, Predicts Atul Kurani Read More »

Pharmacy Careers Prove Resilient Against Economic Fluctuations; Present Diverse Opportunities

The field of pharmacy is often regarded as resistant to economic downturns, thanks to various factors that bolster its stability. Continuous progress in pharmaceutical sciences and the rising demand for skilled professionals in healthcare make a pharmacy career attractive even

Pharmacy Careers Prove Resilient Against Economic Fluctuations; Present Diverse Opportunities Read More »